Verubecestat TFA, also known as MK-8931 or SCH 900931, is a potent and selective beta-secretase inhibitor, and BACE1 protein inhibitor or Beta-site APP-cleaving enzyme 1 inhibitor. Verubecestat TFA is a promising novel therapeutic drug candidate in Alzheimers disease. Verubecestat TFA reduced Abeta cerebral spinal fluids (CSF) levels up to 92% and was well tolerated by patients.
Molecular Weight:
523.435
CAS Number:
[2095432-65-6]
Formula:
C19H18F5N5O5S
Target:
Others|||Beta-Secretase
T71899
* VAT and and shipping costs not included. Errors and price changes excepted
